Pyridinium crosslinks as markers of bone resorption
- 1 August 1992
- journal article
- editorial
- Published by Elsevier in The Lancet
- Vol. 340 (8814) , 278-279
- https://doi.org/10.1016/0140-6736(92)92363-k
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Clinical use of biochemical markers of bone remodeling in osteoporosisBone, 1992
- Urinary excretion of pyridinium crosslinks of collagen in patients with osteoporosis and the effects of bone fracture.Annals of the Rheumatic Diseases, 1992
- New biomarkers of bone resorption.Journal of Clinical Endocrinology & Metabolism, 1992
- Urinary hydroxypyridinium cross-links of collagen in primary hyperparathyroidismJournal of Clinical Endocrinology & Metabolism, 1992
- Evaluation of urinary hydroxypyridinium crosslink measurements as resorption markers in metabolic bone diseasesEuropean Journal of Clinical Investigation, 1991
- Urinary excretion of pyridinoline crosslinks correlates with bone turnover measured on iliac crest biopsy in patients with vertebral osteoporosisJournal of Bone and Mineral Research, 1991
- Effect of Menopause and Hormone Replacement Therapy on the Urinary Excretion of Pyridinium Cross-LinksJournal of Clinical Endocrinology & Metabolism, 1991
- Urinary excretion of pyridinium crosslinks: a new marker of bone resorption in metabolic bone diseaseBone and Mineral, 1990
- Quantitative analysis of the pyridinium crosslinks of collagen in urine using ion-paired reversed-phase high-performance liquid chromatographyAnalytical Biochemistry, 1988
- Quantitation of hydroxypyridinium crosslinks in collagen by high-performance liquid chromatographyAnalytical Biochemistry, 1984